In preclinical models, catestatin exhibits anti-inflammatory, antihypertensive, and metabolic effects, and reduced circulating levels have been associated with hypertension, obesity, and insulin resistance ( Despite these associations, catestatin has received limited attention as a therapeutic candidate, in part because it does not conform neatly to classical endocrine paradigms and lacks a single dominant receptor target
Weight-maintenance RCT (N = 803): Nondiabetic participants were given GLP1/GIP medication weekly for 20 weeks and then randomized to either continued GLP1/GIP medication or PC
Used with diet and exercise, Ozempic (semaglutide) is an injectable medication for the treatment of type 2 diabetes in adults
Patients exploring dual-peptide protocols deserve precision-guided decision-making rather than generic protocol selection
Financial Crime Activity by State Suspicious activity has been rising in the U.S., but is it spread evenly throughout all 50 states